Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 284 Specimen Handling 278 pembrolizumab 255 Cyclophosphamide 234 Radiotherapy 224 Nivolumab 182 Cisplatin 172 Biopsy 163 Carboplatin 152 Radiosurgery 139 fludarabine 128 Blood Specimen Collection 128 Surveys and Questionnaires 117 Gemcitabine 117 Paclitaxel 114 Standard of Care 110 venetoclax 109 Dexamethasone 103 Bevacizumab 96 Radiation 92 Rituximab 89 Oxaliplatin 86 Capecitabine 86 Cytarabine 85 Drug Therapy 83 Ipilimumab 81 Doxorubicin 81 durvalumab 80 atezolizumab 74 fludarabine phosphate 73

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Chemoradiotherapy, Adjuvant × 90 days × Clear all

NCT05667298 2026-05-11

OPERARADIO

University of Manitoba

Phase 1 Active not recruiting

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡